2-(2-bromo-2-propen-1-yl)-1,3-propanediol | 532934-66-0

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 乙烯基卤化物
• 英文名称: 2-(2-bromo-2-propen-1-yl)-1,3-propanediol
• 英文别名: 2-(2-bromoallyl)-propane-1,3-diol；2-(2-Bromoallyl)propane-1,3-diol；2-(2-bromoprop-2-enyl)propane-1,3-diol
• CAS: 532934-66-0
• 化学式: C₆H₁₁BrO₂
• 分子量: 195.056
• InChiKey: VNRMZEYOKAVMTB-UHFFFAOYSA-N

物化性质

• 沸点：
  297.6±40.0 °C(Predicted)
• 密度：
  1.488±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(2-bromo-2-propen-1-yl)-1,3-propanediol 在 4-二甲氨基吡啶 、 四(三苯基膦)钯 、 potassium carbonate 、 cesium fluoride 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 28.0h， 生成 2-(2-phenylallyl)propane-1,3-diol
  参考文献：
  名称：

  Catalytic Asymmetric Bromoetherification and Desymmetrization of Olefinic 1,3-Diols with C₂-Symmetric Sulfides

  摘要：

  An enantioselective and highly diastereoselective bromoetherification and desymmetrization of olefinic 1,3-diols has been developed using a C-2-symmetric cyclic sulfide catalyst. This methodology has been successfully applied to the synthesis of the key intermediate of an orally active antifungal drug posaconazole (Noxafil).

  DOI：

  10.1021/ja5029155
• 作为产物：
  描述：

  dimethyl 2-(2'-bromoallyl)malonate 在 lithium aluminium tetrahydride 、 水 作用下， 以 乙醚 为溶剂， 反应 3.0h， 以86%的产率得到2-(2-bromo-2-propen-1-yl)-1,3-propanediol
  参考文献：
  名称：

  WO2007/14011

  摘要：

  公开号：

文献信息

• THIAZOLE DERIVATIVE
  申请人：Astellas Pharma Inc.

  公开号：EP1921074A1

  公开（公告）日：2008-05-14

  [Problem] To provide a compound which is useful as a GK activator. [Means for Resolution] As a result of an extensive study on thiazole derivatives, the present inventors have found that a compound having an oxamoyl group, a glycol group or the like on a thiazole ring and a compound having an acetamide group substituted by a bicyclic heteroaryl group such as a quinolyl have a good GK activation effect, and thereby have accomplished the present invention. Since the compounds of the present invention have a good GK activation effect, these are useful as therapeutic agents for diabetes, particularly type II diabetes.

  [问题] 提供一种作为GK激活剂有用的化合物。[解决方法] 通过对噻唑衍生物进行广泛研究，本发明人发现，在噻唑环上具有氧羰基、甘醇基或类似基团的化合物，以及在乙酰胺基团上被双环杂环芳基团（如喹啉基）取代的化合物具有良好的GK激活效果，从而完成了本发明。由于本发明的化合物具有良好的GK激活效果，因此它们可用作糖尿病的治疗药物，特别是II型糖尿病。
• A novel synthesis of tetrahydrofuran via alkoxy radical cyclisation
  作者：Masahiro Yokota、Masahiro Toyota、Masataka Ihara

  DOI：10.1039/b211568a

  日期：2003.1.23

  Tetrahydrofurans were synthesised via 5-exo-trig cyclisation of alkoxy radical generated by unprecedented 1,5-hydrogen shift from hydroxyl group to vinyl radical.

  四氢呋喃是通过烷氧基的5-exo-trig环化反应合成的，该烷氧基是由前所未有的1，5-氢从羟基转变为乙烯基所产生的。
• DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
  申请人：Maderna Andreas

  公开号：US20080058340A1

  公开（公告）日：2008-03-06

  This invention concerns N-(2-arylamino) aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.

  这项发明涉及N-(2-芳基氨基)芳基磺酰胺，它们是MEK的抑制剂，可用于治疗癌症和其他过度增殖性疾病。
• DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES INCLUDING POLYMORPHS AS INHIBITORS OF MEK AS WELL AS COMPOSITIONS, METHODS OF USE AND METHODS FOR PREPARING THE SAME
  申请人：Vernier Jean-Michel

  公开号：US20110060049A1

  公开（公告）日：2011-03-10

  This invention concerns N-(2-arylamino) aryl sulfonamide compounds which are inhibitors of MEK including crystalline polymorphic forms which exhibit a specific powder x-ray diffraction profile and/or a specific differential scanning calorimetry profile. This invention also concerns pharmaceutical compositions comprising the compounds described herein and methods of use of the compounds and compositions described herein, including the use in the treatment and/or prevention of cancer, hyperproliferative diseases and inflammatory conditions. The invention also concerns methods of making the compounds and compositions described herein.

  本发明涉及N-(2-芳基氨基)芳基磺酰胺化合物，其是MEK抑制剂，包括具有特定粉末X射线衍射谱和/或特定差示扫描量热谱的晶体多态形式。本发明还涉及包含所述化合物的制药组合物及所述化合物和组合物的使用方法，包括在治疗和/或预防癌症、高增殖性疾病和炎症疾病中的使用。本发明还涉及制备所述化合物和组合物的方法。
• Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
  申请人：Ardea Biosciences

  公开号：US07759518B2

  公开（公告）日：2010-07-20

  This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.

  这项发明涉及N-(2-芳基氨基)芳基磺酰胺，它们是MEK的抑制剂，并且在治疗癌症和其他过度增殖性疾病方面非常有用。